CXCL10 levels in cerebrospinal fluid (CSF) were higher in patients with AD and mild cognitive impairment, possibly based on caspase-dependent CXCL10-induced apoptosis of fetal neurons [42]. The gene discussed is CXCL10; the disease is Alzheimer disease.